Doctor’s Guide -- CHICAGO -- October 18, 2010 -- A multicentre review looking at the use of anti-vascular endothelial growth factor (VEGF) inhibitors in the treatment of retinopathy of prematurity (ROP) reports that these injections are safe and beneficial for many infants.
